Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

James M. Hogle, Ph.D.

TitleEdward S. Harkness Professor of Biological Chemistry and Molecular Pharmacology
InstitutionHarvard Medical School
DepartmentBiological Chemistry & Molecular Pharmacology
AddressHarvard Medical School
Bio Chem and Mol Pharm
240 Longwood Ave
Boston MA 02115
Phone617/432-3918
Fax617/432-4360

 Mentoring 
 completed student projects
Towards a Structural Understanding of Poliovirus Cell Entry
Part Time, 02/01/99 - 06/18/99

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Butan C, Filman DJ, Hogle JM. Cryo-Electron Microscopy Reconstruction Shows Poliovirus 135S Particles Poised for Membrane Interaction and RNA Release. J Virol. 2014 Feb; 88(3):1758-70.
    View in: PubMed
  2. Lin J, Cheng N, Hogle JM, Steven AC, Belnap DM. Conformational shift of a major poliovirus antigen confirmed by immuno-cryogenic electron microscopy. J Immunol. 2013 Jul 15; 191(2):884-91.
    View in: PubMed
  3. Strauss M, Levy HC, Bostina M, Filman DJ, Hogle JM. RNA Transfer from Poliovirus 135S Particles across Membranes Is Mediated by Long Umbilical Connectors. J Virol. 2013 Apr; 87(7):3903-14.
    View in: PubMed
  4. Hogle JM. A 3D framework for understanding enterovirus 71. Nat Struct Mol Biol. 2012; 19(4):367-8.
    View in: PubMed
  5. Lin J, Lee LY, Roivainen M, Filman DJ, Hogle JM, Belnap DM. Structure of the Fab-labeled "breathing" state of native poliovirus. J Virol. 2012 May; 86(10):5959-62.
    View in: PubMed
  6. Lin J, Cheng N, Chow M, Filman DJ, Steven AC, Hogle JM, Belnap DM. An externalized polypeptide partitions between two distinct sites on genome-released poliovirus particles. J Virol. 2011 Oct; 85(19):9974-83.
    View in: PubMed
  7. Bostina M, Levy H, Filman DJ, Hogle JM. Poliovirus RNA is released from the capsid near a twofold symmetry axis. J Virol. 2011 Jan; 85(2):776-83.
    View in: PubMed
  8. Levy HC, Bostina M, Filman DJ, Hogle JM. Catching a virus in the act of RNA release: a novel poliovirus uncoating intermediate characterized by cryo-electron microscopy. J Virol. 2010 May; 84(9):4426-41.
    View in: PubMed
  9. Tuthill TJ, Groppelli E, Hogle JM, Rowlands DJ. Picornaviruses. Curr Top Microbiol Immunol. 2010; 343:43-89.
    View in: PubMed
  10. Vaughan JC, Brandenburg B, Hogle JM, Zhuang X. Rapid actin-dependent viral motility in live cells. Biophys J. 2009 Sep 16; 97(6):1647-56.
    View in: PubMed
  11. Baltz JL, Filman DJ, Ciustea M, Silverman JE, Lautenschlager CL, Coen DM, Ricciardi RP, Hogle JM. The crystal structure of PF-8, the DNA polymerase accessory subunit from Kaposi's sarcoma-associated herpesvirus. J Virol. 2009 Dec; 83(23):12215-28.
    View in: PubMed
  12. Sam MD, Evans BT, Coen DM, Hogle JM. Biochemical, biophysical, and mutational analyses of subunit interactions of the human cytomegalovirus nuclear egress complex. J Virol. 2009 Apr; 83(7):2996-3006.
    View in: PubMed
  13. Yang JC, Ji J, Hogle JM, Larson DN. Multiplexed plasmonic sensing based on small-dimension nanohole arrays and intensity interrogation. Biosens Bioelectron. 2009 Apr 15; 24(8):2334-8.
    View in: PubMed
  14. Yang JC, Ji J, Hogle JM, Larson DN. Metallic nanohole arrays on fluoropolymer substrates as small label-free real-time bioprobes. Nano Lett. 2008 Sep; 8(9):2718-24.
    View in: PubMed
  15. Komazin-Meredith G, Petrella RJ, Santos WL, Filman DJ, Hogle JM, Verdine GL, Karplus M, Coen DM. The human cytomegalovirus UL44 C clamp wraps around DNA. Structure. 2008 Aug 6; 16(8):1214-25.
    View in: PubMed
  16. Bubeck D, Filman DJ, Kuzmin M, Fuller SD, Hogle JM. Post-imaging fiducial markers aid in the orientation determination of complexes with mixed or unknown symmetry. J Struct Biol. 2008 Jun; 162(3):480-90.
    View in: PubMed
  17. Komazin-Meredith G, Santos WL, Filman DJ, Hogle JM, Verdine GL, Coen DM. The positively charged surface of herpes simplex virus UL42 mediates DNA binding. J Biol Chem. 2008 Mar 7; 283(10):6154-61.
    View in: PubMed
  18. Bostina M, Bubeck D, Schwartz C, Nicastro D, Filman DJ, Hogle JM. Single particle cryoelectron tomography characterization of the structure and structural variability of poliovirus-receptor-membrane complex at 30 A resolution. J Struct Biol. 2007 Nov; 160(2):200-10.
    View in: PubMed
  19. Brandenburg B, Lee LY, Lakadamyali M, Rust MJ, Zhuang X, Hogle JM. Imaging poliovirus entry in live cells. PLoS Biol. 2007 Jul; 5(7):e183.
    View in: PubMed
  20. Baron MJ, Filman DJ, Prophete GA, Hogle JM, Madoff LC. Identification of a glycosaminoglycan binding region of the alpha C protein that mediates entry of group B Streptococci into host cells. J Biol Chem. 2007 Apr 6; 282(14):10526-36.
    View in: PubMed
  21. Marcotte LL, Wass AB, Gohara DW, Pathak HB, Arnold JJ, Filman DJ, Cameron CE, Hogle JM. Crystal structure of poliovirus 3CD protein: virally encoded protease and precursor to the RNA-dependent RNA polymerase. J Virol. 2007 Apr; 81(7):3583-96.
    View in: PubMed
  22. Tuthill TJ, Bubeck D, Rowlands DJ, Hogle JM. Characterization of early steps in the poliovirus infection process: receptor-decorated liposomes induce conversion of the virus to membrane-anchored entry-intermediate particles. J Virol. 2006 Jan; 80(1):172-80.
    View in: PubMed
  23. Appleton BA, Brooks J, Loregian A, Filman DJ, Coen DM, Hogle JM. Crystal structure of the cytomegalovirus DNA polymerase subunit UL44 in complex with the C terminus from the catalytic subunit. Differences in structure and function relative to unliganded UL44. J Biol Chem. 2006 Feb 24; 281(8):5224-32.
    View in: PubMed
  24. Bryant KF, Cox JC, Wang H, Hogle JM, Ellington AD, Coen DM. Binding of herpes simplex virus-1 US11 to specific RNA sequences. Nucleic Acids Res. 2005; 33(19):6090-100.
    View in: PubMed
  25. Robinson MA, Park S, Sun ZY, Silver PA, Wagner G, Hogle JM. Multiple conformations in the ligand-binding site of the yeast nuclear pore-targeting domain of Nup116p. J Biol Chem. 2005 Oct 21; 280(42):35723-32.
    View in: PubMed
  26. Bubeck D, Filman DJ, Hogle JM. Cryo-electron microscopy reconstruction of a poliovirus-receptor-membrane complex. Nat Struct Mol Biol. 2005 Jul; 12(7):615-8.
    View in: PubMed
  27. Bubeck D, Filman DJ, Cheng N, Steven AC, Hogle JM, Belnap DM. The structure of the poliovirus 135S cell entry intermediate at 10-angstrom resolution reveals the location of an externalized polypeptide that binds to membranes. J Virol. 2005 Jun; 79(12):7745-55.
    View in: PubMed
  28. Aupérin TC, Bolduc GR, Baron MJ, Heroux A, Filman DJ, Madoff LC, Hogle JM. Crystal structure of the N-terminal domain of the group B streptococcus alpha C protein. J Biol Chem. 2005 May 6; 280(18):18245-52.
    View in: PubMed
  29. Guogas LM, Filman DJ, Hogle JM, Gehrke L. Cofolding organizes alfalfa mosaic virus RNA and coat protein for replication. Science. 2004 Dec 17; 306(5704):2108-11.
    View in: PubMed
  30. Loregian A, Appleton BA, Hogle JM, Coen DM. Specific residues in the connector loop of the human cytomegalovirus DNA polymerase accessory protein UL44 are crucial for interaction with the UL54 catalytic subunit. J Virol. 2004 Sep; 78(17):9084-92.
    View in: PubMed
  31. Appleton BA, Loregian A, Filman DJ, Coen DM, Hogle JM. The cytomegalovirus DNA polymerase subunit UL44 forms a C clamp-shaped dimer. Mol Cell. 2004 Jul 23; 15(2):233-44.
    View in: PubMed
  32. Loregian A, Appleton BA, Hogle JM, Coen DM. Residues of human cytomegalovirus DNA polymerase catalytic subunit UL54 that are necessary and sufficient for interaction with the accessory protein UL44. J Virol. 2004 Jan; 78(1):158-67.
    View in: PubMed
  33. Hogle JM. Poliovirus cell entry: common structural themes in viral cell entry pathways. Annu Rev Microbiol. 2002; 56:677-702.
    View in: PubMed
  34. Joseph-McCarthy D, Tsang SK, Filman DJ, Hogle JM, Karplus M. Use of MCSS to design small targeted libraries: application to picornavirus ligands. J Am Chem Soc. 2001 Dec 26; 123(51):12758-69.
    View in: PubMed
  35. Jia Q, Hogle JM, Hashikawa T, Nomoto A. Molecular genetic analysis of revertants from a poliovirus mutant that is specifically adapted to the mouse spinal cord. J Virol. 2001 Dec; 75(23):11766-72.
    View in: PubMed
  36. Bitetti-Putzer R, Joseph-McCarthy D, Hogle JM, Karplus M. Functional group placement in protein binding sites: a comparison of GRID and MCSS. J Comput Aided Mol Des. 2001 Oct; 15(10):935-60.
    View in: PubMed
  37. Tsang SK, McDermott BM, Racaniello VR, Hogle JM. Kinetic analysis of the effect of poliovirus receptor on viral uncoating: the receptor as a catalyst. J Virol. 2001 Jun; 75(11):4984-9.
    View in: PubMed
  38. Miller ST, Hogle JM, Filman DJ. Ab initio phasing of high-symmetry macromolecular complexes: successful phasing of authentic poliovirus data to 3.0 A resolution. J Mol Biol. 2001 Mar 23; 307(2):499-512.
    View in: PubMed
  39. Tsang SK, Cheh J, Isaacs L, Joseph-McCarthy D, Choi SK, Pevear DC, Whitesides GM, Hogle JM. A structurally biased combinatorial approach for discovering new anti-picornaviral compounds. Chem Biol. 2001 Jan; 8(1):33-45.
    View in: PubMed
  40. Weiss VH, McBride AE, Soriano MA, Filman DJ, Silver PA, Hogle JM. The structure and oligomerization of the yeast arginine methyltransferase, Hmt1. Nat Struct Biol. 2000 Dec; 7(12):1165-71.
    View in: PubMed
  41. Elkin CD, Zuccola HJ, Hogle JM, Joseph-McCarthy D. Computational design of D-peptide inhibitors of hepatitis delta antigen dimerization. J Comput Aided Mol Des. 2000 Nov; 14(8):705-18.
    View in: PubMed
  42. Huang Y, Hogle JM, Chow M. Is the 135S poliovirus particle an intermediate during cell entry? J Virol. 2000 Sep; 74(18):8757-61.
    View in: PubMed
  43. Moraleda G, Dingle K, Biswas P, Chang J, Zuccola H, Hogle J, Taylor J. Interactions between hepatitis delta virus proteins. J Virol. 2000 Jun; 74(12):5509-15.
    View in: PubMed
  44. Tsang SK, Danthi P, Chow M, Hogle JM. Stabilization of poliovirus by capsid-binding antiviral drugs is due to entropic effects. J Mol Biol. 2000 Feb 18; 296(2):335-40.
    View in: PubMed
  45. McBride AE, Weiss VH, Kim HK, Hogle JM, Silver PA. Analysis of the yeast arginine methyltransferase Hmt1p/Rmt1p and its in vivo function. Cofactor binding and substrate interactions. J Biol Chem. 2000 Feb 4; 275(5):3128-36.
    View in: PubMed
  46. Zuccola HJ, Filman DJ, Coen DM, Hogle JM. The crystal structure of an unusual processivity factor, herpes simplex virus UL42, bound to the C terminus of its cognate polymerase. Mol Cell. 2000 Feb; 5(2):267-78.
    View in: PubMed
  47. Belnap DM, Filman DJ, Trus BL, Cheng N, Booy FP, Conway JF, Curry S, Hiremath CN, Tsang SK, Steven AC, Hogle JM. Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus. J Virol. 2000 Feb; 74(3):1342-54.
    View in: PubMed
  48. Belnap DM, McDermott BM, Filman DJ, Cheng N, Trus BL, Zuccola HJ, Racaniello VR, Hogle JM, Steven AC. Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc Natl Acad Sci U S A. 2000 Jan 4; 97(1):73-8.
    View in: PubMed
  49. Hindiyeh M, Li QH, Basavappa R, Hogle JM, Chow M. Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4. J Virol. 1999 Nov; 73(11):9072-9.
    View in: PubMed
  50. Trikha J, Filman DJ, Hogle JM. Crystal structure of a 14 bp RNA duplex with non-symmetrical tandem GxU wobble base pairs. Nucleic Acids Res. 1999 Apr 1; 27(7):1728-39.
    View in: PubMed
  51. Huang L, Ishii KK, Zuccola H, Gehring AM, Hwang CB, Hogle J, Coen DM. The enzymological basis for resistance of herpesvirus DNA polymerase mutants to acyclovir: relationship to the structure of alpha-like DNA polymerases. Proc Natl Acad Sci U S A. 1999 Jan 19; 96(2):447-52.
    View in: PubMed
  52. Filman DJ, Wien MW, Cunningham JA, Bergelson JM, Hogle JM. Structure determination of echovirus 1. Acta Crystallogr D Biol Crystallogr. 1998 Nov 1; 54(Pt 6 Pt 2):1261-72.
    View in: PubMed
  53. Basavappa R, Gómez-Yafal A, Hogle JM. The poliovirus empty capsid specifically recognizes the poliovirus receptor and undergoes some, but not all, of the transitions associated with cell entry. J Virol. 1998 Sep; 72(9):7551-6.
    View in: PubMed
  54. Zuccola HJ, Rozzelle JE, Lemon SM, Erickson BW, Hogle JM. Structural basis of the oligomerization of hepatitis delta antigen. Structure. 1998 Jul 15; 6(7):821-30.
    View in: PubMed
  55. Dingle K, Bichko V, Zuccola H, Hogle J, Taylor J. Initiation of hepatitis delta virus genome replication. J Virol. 1998 Jun; 72(6):4783-8.
    View in: PubMed
  56. Grant RA, Filman DJ, Finkel SE, Kolter R, Hogle JM. The crystal structure of Dps, a ferritin homolog that binds and protects DNA. Nat Struct Biol. 1998 Apr; 5(4):294-303.
    View in: PubMed
  57. Hiremath CN, Filman DJ, Grant RA, Hogle JM. Ligand-induced conformational changes in poliovirus-antiviral drug complexes. Acta Crystallogr D Biol Crystallogr. 1997 Sep 1; 53(Pt 5):558-70.
    View in: PubMed
  58. Joseph-McCarthy D, Hogle JM, Karplus M. Use of the multiple copy simultaneous search (MCSS) method to design a new class of picornavirus capsid binding drugs. Proteins. 1997 Sep; 29(1):32-58.
    View in: PubMed
  59. Wien MW, Curry S, Filman DJ, Hogle JM. Structural studies of poliovirus mutants that overcome receptor defects. Nat Struct Biol. 1997 Aug; 4(8):666-74.
    View in: PubMed
  60. Benson TE, Walsh CT, Hogle JM. X-ray crystal structures of the S229A mutant and wild-type MurB in the presence of the substrate enolpyruvyl-UDP-N-acetylglucosamine at 1.8-A resolution. Biochemistry. 1997 Jan 28; 36(4):806-11.
    View in: PubMed
  61. Curry S, Chow M, Hogle JM. The poliovirus 135S particle is infectious. J Virol. 1996 Oct; 70(10):7125-31.
    View in: PubMed
  62. Wien MW, Chow M, Hogle JM. Poliovirus: new insights from an old paradigm. Structure. 1996 Jul 15; 4(7):763-7.
    View in: PubMed
  63. Jacobson DH, Hogle JM, Filman DJ. A pseudo-cell based approach to efficient crystallographic refinement of viruses. Acta Crystallogr D Biol Crystallogr. 1996 Jul 1; 52(Pt 4):693-711.
    View in: PubMed
  64. Miller ST, Hogle JM, Filman DJ. A genetic algorithm for the ab initio phasing of icosahedral viruses. Acta Crystallogr D Biol Crystallogr. 1996 Mar 1; 52(Pt 2):235-51.
    View in: PubMed
  65. Lees WJ, Benson TE, Hogle JM, Walsh CT. (E)-enolbutyryl-UDP-N-acetylglucosamine as a mechanistic probe of UDP-N-acetylenolpyruvylglucosamine reductase (MurB). Biochemistry. 1996 Feb 6; 35(5):1342-51.
    View in: PubMed
  66. Benson TE, Walsh CT, Hogle JM. The structure of the substrate-free form of MurB, an essential enzyme for the synthesis of bacterial cell walls. Structure. 1996 Jan 15; 4(1):47-54.
    View in: PubMed
  67. Benson TE, Filman DJ, Walsh CT, Hogle JM. An enzyme-substrate complex involved in bacterial cell wall biosynthesis. Nat Struct Biol. 1995 Aug; 2(8):644-53.
    View in: PubMed
  68. Hiremath CN, Grant RA, Filman DJ, Hogle JM. Binding of the antiviral drug WIN51711 to the sabin strain of type 3 poliovirus: structural comparison with drug binding in rhinovirus 14. Acta Crystallogr D Biol Crystallogr. 1995 Jul 1; 51(Pt 4):473-89.
    View in: PubMed
  69. Wien MW, Filman DJ, Stura EA, Guillot S, Delpeyroux F, Crainic R, Hogle JM. Structure of the complex between the Fab fragment of a neutralizing antibody for type 1 poliovirus and its viral epitope. Nat Struct Biol. 1995 Mar; 2(3):232-43.
    View in: PubMed
  70. Couderc T, Guédo N, Calvez V, Pelletier I, Hogle J, Colbère-Garapin F, Blondel B. Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mice. J Virol. 1994 Dec; 68(12):8386-91.
    View in: PubMed
  71. Basavappa R, Syed R, Flore O, Icenogle JP, Filman DJ, Hogle JM. Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution. Protein Sci. 1994 Oct; 3(10):1651-69.
    View in: PubMed
  72. Grant RA, Hiremath CN, Filman DJ, Syed R, Andries K, Hogle JM. Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr Biol. 1994 Sep 1; 4(9):784-97.
    View in: PubMed
  73. Benson TE, Walsh CT, Hogle JM. Crystallization and preliminary X-ray crystallographic studies of UDP-N-acetylenolpyruvylglucosamine reductase. Protein Sci. 1994 Jul; 3(7):1125-7.
    View in: PubMed
  74. Li Q, Yafal AG, Lee YM, Hogle J, Chow M. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature. J Virol. 1994 Jun; 68(6):3965-70.
    View in: PubMed
  75. Jarousse N, Fiette L, Grant RA, Hogle JM, McAllister A, Michiels T, Aubert C, Tangy F, Brahic M, Peña Rossi C. Chimeric Theiler's virus with altered tropism for the central nervous system. J Virol. 1994 May; 68(5):2781-6.
    View in: PubMed
  76. Jarousse N, Grant RA, Hogle JM, Zhang L, Senkowski A, Roos RP, Michiels T, Brahic M, McAllister A. A single amino acid change determines persistence of a chimeric Theiler's virus. J Virol. 1994 May; 68(5):3364-8.
    View in: PubMed
  77. Morrison ME, He YJ, Wien MW, Hogle JM, Racaniello VR. Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication. J Virol. 1994 Apr; 68(4):2578-88.
    View in: PubMed
  78. Gómez Yafal A, Kaplan G, Racaniello VR, Hogle JM. Characterization of poliovirus conformational alteration mediated by soluble cell receptors. Virology. 1993 Nov; 197(1):501-5.
    View in: PubMed
  79. Moscufo N, Yafal AG, Rogove A, Hogle J, Chow M. A mutation in VP4 defines a new step in the late stages of cell entry by poliovirus. J Virol. 1993 Aug; 67(8):5075-8.
    View in: PubMed
  80. Couderc T, Hogle J, Le Blay H, Horaud F, Blondel B. Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell. J Virol. 1993 Jul; 67(7):3808-17.
    View in: PubMed
  81. Syed R, Wu ZP, Hogle JM, Hilvert D. Crystal structure of selenosubtilisin at 2.0-A resolution. Biochemistry. 1993 Jun 22; 32(24):6157-64.
    View in: PubMed
  82. Hogle JM. Virus-ligand structures: the viral canyon. Curr Biol. 1993 May 1; 3(5):278-81.
    View in: PubMed
  83. Dedieu JF, Ronco J, van der Werf S, Hogle JM, Henin Y, Girard M. Poliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type 1. J Virol. 1992 May; 66(5):3161-7.
    View in: PubMed
  84. Grant RA, Filman DJ, Fujinami RS, Icenogle JP, Hogle JM. Three-dimensional structure of Theiler virus. Proc Natl Acad Sci U S A. 1992 Mar 15; 89(6):2061-5.
    View in: PubMed
  85. Yeates TO, Jacobson DH, Martin A, Wychowski C, Girard M, Filman DJ, Hogle JM. Three-dimensional structure of a mouse-adapted type 2/type 1 poliovirus chimera. EMBO J. 1991 Sep; 10(9):2331-41.
    View in: PubMed
  86. Filman DJ, Hogle JM. Virology. Architecture with a difference. Nature. 1991 May 9; 351(6322):100-1.
    View in: PubMed
  87. Muir S, Weintraub JP, Hogle J, Bittle JL. Neutralizing antibody to Mengo virus, induced by synthetic peptides. J Gen Virol. 1991 May; 72 ( Pt 5):1087-92.
    View in: PubMed
  88. Martin A, Benichou D, Couderc T, Hogle JM, Wychowski C, Van der Werf S, Girard M. Use of type 1/type 2 chimeric polioviruses to study determinants of poliovirus type 1 neurovirulence in a mouse model. Virology. 1991 Feb; 180(2):648-58.
    View in: PubMed
  89. Fricks CE, Hogle JM. Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding. J Virol. 1990 May; 64(5):1934-45.
    View in: PubMed
  90. Zurbriggen A, Hogle JM, Fujinami RS. Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus. J Exp Med. 1989 Dec 1; 170(6):2037-49.
    View in: PubMed
  91. Hogle JM, Filman DJ. The antigenic structure of poliovirus. Philos Trans R Soc Lond B Biol Sci. 1989 Jun 12; 323(1217):467-78.
    View in: PubMed
  92. Filman DJ, Syed R, Chow M, Macadam AJ, Minor PD, Hogle JM. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 1989 May; 8(5):1567-79.
    View in: PubMed
  93. Hogle JM, Filman DJ. Poliovirus: three-dimensional structure of a viral antigen. Adv Vet Sci Comp Med. 1989; 33:65-91.
    View in: PubMed
  94. Ypma-Wong MF, Filman DJ, Hogle JM, Semler BL. Structural domains of the poliovirus polyprotein are major determinants for proteolytic cleavage at Gln-Gly pairs. J Biol Chem. 1988 Nov 25; 263(33):17846-56.
    View in: PubMed
  95. Martin A, Wychowski C, Couderc T, Crainic R, Hogle J, Girard M. Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. EMBO J. 1988 Sep; 7(9):2839-47.
    View in: PubMed
  96. Page GS, Mosser AG, Hogle JM, Filman DJ, Rueckert RR, Chow M. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J Virol. 1988 May; 62(5):1781-94.
    View in: PubMed
  97. Hogle JM. Antigenic hybrids of poliovirus. Nature. 1988 Mar 3; 332(6159):13-4.
    View in: PubMed
  98. Chow M, Newman JF, Filman D, Hogle JM, Rowlands DJ, Brown F. Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature. 1987 Jun 11-17; 327(6122):482-6.
    View in: PubMed
  99. Hogle JM, Chow M, Filman DJ. The structure of poliovirus. Sci Am. 1987 Mar; 256(3):42-9.
    View in: PubMed
  100. Hogle JM, Maeda A, Harrison SC. Structure and assembly of turnip crinkle virus. I. X-ray crystallographic structure analysis at 3.2 A resolution. J Mol Biol. 1986 Oct 20; 191(4):625-38.
    View in: PubMed
  101. Icenogle JP, Minor PD, Ferguson M, Hogle JM. Modulation of humoral response to a 12-amino-acid site on the poliovirus virion. J Virol. 1986 Oct; 60(1):297-301.
    View in: PubMed
  102. Hogle JM, Chow M, Filman DJ. Three-dimensional structure of poliovirus at 2.9 A resolution. Science. 1985 Sep 27; 229(4720):1358-65.
    View in: PubMed
  103. Fricks CE, Icenogle JP, Hogle JM. Trypsin sensitivity of the Sabin strain of type 1 poliovirus: cleavage sites in virions and related particles. J Virol. 1985 Jun; 54(3):856-9.
    View in: PubMed
  104. Chow M, Yabrov R, Bittle J, Hogle J, Baltimore D. Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies. Proc Natl Acad Sci U S A. 1985 Feb; 82(3):910-4.
    View in: PubMed
  105. Hogle J, Kirchhausen T, Harrison SC. Divalent cation sites in tomato bushy stunt virus. Difference maps at 2-9 A resolution. J Mol Biol. 1983 Nov 25; 171(1):95-100.
    View in: PubMed
  106. Niman HL, Houghten RA, Walker LE, Reisfeld RA, Wilson IA, Hogle JM, Lerner RA. Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proc Natl Acad Sci U S A. 1983 Aug; 80(16):4949-53.
    View in: PubMed
  107. Hogle JM. Preliminary studies of crystals of poliovirus type I. J Mol Biol. 1982 Oct 5; 160(4):663-8.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Hogle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_